Yourgene have worked closely with Key Opinion Leaders, high profile partners, customers and market renowned experts within their chosen fields to develop a series of Your Expert papers. We aim to cover a range of different topics and content relevant to the portfolio of applications that Yourgene operates in. We hope these papers serve as relevant, informative and educational resources.
Fluorouracil (5-FU) and Capecitabine, a prodrug of 5-FU, are fluoropyrimidine chemotherapy agents used in the treatment of cancer. These drugs form a key component of the chemotherapy regime for colorectal, breast, heapato-pancreato-biliary and many other cancers.
Through high throughput techniques, NGS technology is able to thoroughly screen and record human gene sequences, supporting the performing of clinical researches and medical diagnoses. Preventive genetic testing can be employed to analyze the risks and risk degrees of the hereditary disease-associated genes for general examinees. Furthermore, diagnosed patients can be tested to provide physicians with background information for the planning of target therapy strategies or the assessing and monitoring of disease recurrences.
The development of prenatal molecular testing has progressed from the early large segment chromosomal abnormality observation method, to DNA microarray technology, then into whole genome sequencing (WGS) and whole exome sequencing (WES), with every stage having its own advantages and disadvantages.
